SOUTH SAN FRANCISCO--(BUSINESS WIRE)-- VistaGen Therapeutics, Inc. (Nasdaq: VTGN) (VistaGen), a late clinical-stage, central nervous system (CNS)-focused biopharmaceutical company aiming to transform ...
In today's fast-paced and ever-changing world, individuals often find themselves grappling with a host of stressors and life transitions. While most people navigate these challenges with resilience, ...
Few studies have been conducted to elucidate the psychological distress of terminally ill cancer patients. This study attempted to determine the prevalence of adjustment disorders (AD), major ...
Twenty-two percent of U.S. doctors prescribing initial treatment for children with a new diagnosis of anxiety or depression during a recent six-year period chose medications that are not federally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results